Olaris
Olaris, Inc | Biomarkers of Response (BoRs) | Framingham, Massachusetts
Framingham, United States · Founded 2014 · $15.0M raised
- Headquarters
- Framingham, Massachusetts
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- myolaris.com
- Total Funding
- $15.0M
- Last Round
- $15.0M Corporate RoundApr 2025
- Rounds
- 4
About
Precision medicine company using metabolomics and machine learning to develop biomarkers of response for drug treatment selection.
Summary
Olaris is a Biotech company based in Framingham, United States, founded in 2014. It has raised $15.0M in total across 4 rounds, most recently a $15.0M Corporate Round round in Apr 2025. Investors include Labcorp, Innospark Ventures and Alumni Ventures.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Apr 2025
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...